Bank Of New York Mellon Corp Exagen Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.18 - $7.74 $108,333 - $200,597	-25,917 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$7.12 - $11.06 $3,410 - $5,297	-479 Reduced 1.81%	25,917 $208,000
Q4 2021 Feb 11, 2022	SELL	$8.97 - $14.08 $50,303 - $78,960	-5,608 Reduced 17.52%	26,396 $307,000
Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $43,716 - $64,870	4,265 Added 15.38%	32,004 $435,000
Q2 2021 Aug 11, 2021	BUY	$12.4 - $17.92 $193,055 - $278,996	15,569 Added 127.93%	27,739 $415,000
Q1 2021 May 13, 2021	SELL	$13.9 - $22.0 $23,657 - $37,444	-1,702 Reduced 12.27%	12,170 $212,000
Q4 2020 Feb 09, 2021	SELL	$11.19 - $16.05 $6,792 - $9,742	-607 Reduced 4.19%	13,872 $183,000
Q3 2020 Nov 12, 2020	SELL	$10.56 - $16.69 $5,691 - $8,995	-539 Reduced 3.59%	14,479 $156,000
Q2 2020 Aug 12, 2020	BUY	$11.0 - $16.7 $165,198 - $250,800	15,018 New	15,018 $186,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.